Print

New ANDA Cases

Case Name

Date Filed

Judge

Drug

Patent
No(s).

Pfizer Inc. v. Roxane Labs., Inc., 12-0593 (S.D. Ohio)

July 3, 2012

Hon. Edmund A. Sargus

Pristiq® (desvenlafaxine)

6,673,838

Endo Pharma. Inc. v. TWI Pharma., Inc., 12-0848 (D. Del.)

July 5, 2012

Hon. Gregory M. Sleet

Lidoderm® Patch (lidocaine)

5,741,510

6,096,334

5,827,529

Cubist Pharma., Inc. v. Hospira, Inc., 12-0859 (D. Del.)

July 9, 2012

Hon. Gregory M. Sleet

Cubicin® (daptomycin for injection)

8,129,342

Shionogi, Inc. v. Nostrum Labs., Inc., 12-4402 (D.N.J.)

July 13, 2012

Hon. Robert B. Kugler

Fortamet® (metformin hydrochloride extended-release tablets)

6,099,859

6,866,866

Novartis Pharma. Corp. v. Sun Pharma. Indus., Inc., 12-4393 (D.N.J.)

July 14, 2012

Hon. Susan D. Wigenton

Zometa® (zoledronic acid)

Reclast® (zoledronic acid)

7,932,241

Alcon Pharma. Ltd. v. Apotex Inc., 12-0960 (D. Del.)

July 20, 2012

Hon. Sue L. Robinson

Vigamox® (moxifloxacin hydrochloride ophthalmic solution)

6,716,830

7,671,070

 

Novartis Pharma. Corp. v. Lupin Ltd., 12-4552 (D.N.J.)

July 20, 2012

Hon. William J. Martini

Diovan HCT® (valsartan / hydrochlorothiazide tablets)

6,294,197

Celgene Corp. v. Natco Pharma. Ltd., 12-4571 (D.N.J.)

July 20, 2012

Hon. Susan D. Wigenton

Revlimid® (lenalidomide capsules)

5,635,517

6,281,230

7,189,740

7,968,569

7,977,357

8,193,219

Purdue Pharma L.P. v. Actavis Elizabeth LLC, 12-5615 (S.D.N.Y.)

July 20, 2012

Hon. Sidney H. Stein

OxyContin® (oxycodone hydrochloride extended-release tablets)

8,114,383

Alcon Pharma. Ltd. v. Lupin Ltd., 12-0973 (D. Del.)

July 24, 2012

Hon. Sue L. Robinson

Moxeza® (moxifloxacin hydrochloride ophthalmic solution)

6,716,830

7,671,070

 

Sunovion Pharma. Inc. v. Watson Pharma., Inc., 12-0993 (D. Del.)

July 27, 2012

Hon. Leonard P. Stark

Xopenex HFA® (levalbuterol tartrate inhalation aerosol)

7,256,310

Southern Research Institute v. Abon Pharma LLC, 12-4709 (D.N.J.)

July 27, 2012

Hon. William J. Martini

Clolar® (clofarabine injection)

5,661,136

Meda Pharma. Inc. v. Cadila Healthcare Ltd., 12-4719 (D.N.J.)

July 27, 2012

Hon. Michael A. Shipp

Astepro® (azelastine 0.15 % nasal spray)

8,071,073

Galderma Labs., L.P. v. Watson Pharma., Inc., 12-2563 (N.D. Tex.)

July 27, 2012

Hon. Ed Kinkeade

Epiduo® (adapalene / benzoyl peroxide gel)

8,071,644

8,080,537

8,129,362

Millenium Pharma. Inc. v. Sandoz Inc., 12-1011 (D. Del.)

Aug. 2, 2012

Hon. Gregory M. Sleet

Velcade® (bortezomib injection)

6,713,446

6,958,319

Astrazeneca Pharma. LP v. Amneal Pharma., LLC, 12-4841 (D.N.J.)

Aug. 2, 2012

Hon. Joel A Pisano

Seroquel XR® (quetiapine fumarate extended-release tablets)

5,948,437

Nycomed Gmbh v. Apotex Inc., 12-1073 (S.D. Ind.)

Aug. 2, 2012

Hon. Tanya W. Pratt

Omnaris® (ciclesonide nasal spray)

6,767,901

6,939,559

7,235,247

Cumberland Pharma. Inc. v. Perrigo Co., 12-6327 (N.D. Ill.)

Aug. 9, 2012

Hon. Ruben Castillo

Acetadote® (acetylcysteine intravenous)

8,148,356

Janssen Pharma., Inc. v. Glenmark Generics Ltd., 12-5009 (D.N.J.)

Aug. 9, 2012

Hon. Stanley R. Chessler

Ortho Tri-Cyclen® LO (norgestimate / ethinyl estradiol)

6,214,815

Luitpold Pharma., Inc. v. Amneal Pharma., LLC, 12-5064 (D.N.J.)

Aug. 10, 2012

Hon. Joel A. Pisano

Sprix® (ketorolac tromethamine nasal spray)

6,333,044

Santarus, Inc. v. Dr. Reddy’s Labs. Inc., 12-5202 (D.N.J.)

Aug. 15, 2012

Hon. Peter G. Sheridan

Zegerid® (omeprazole / sodium bicarbonate capsules)

6,699,885

6,489,346

6,645,988

7,399,772

Gilead Sciences, Inc. v. Lupin Ltd., 12-6293 (S.D.N.Y.)

Aug. 16, 2012

Hon. Richard J. Sullivan

Emtriva® (emtricitabine capsules)

6,642,245

6,703,396

Merck Sharp & Dohme Corp. v. Watson Labs., Inc., 12-5228 (D.N.J.)

Aug. 20, 2012

Hon. Freda L. Wolfson

Propecia® (finasteride tablets)

5,571,817

5,547,957

Gilead Sciences, Inc. v. Cipla Ltd., 12-6350 (S.D.N.Y.)

Aug. 20, 2012

Hon. Richard J. Sullivan

Emtriva® (emtricitabine capsules)

6,642,245

6,703,396

Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.p.A. v. Actavis South Atlantic LLC, 12-1061 (D. Del.)

Aug. 21, 2012

Hon. Leonard P. Stark

Oleptro® (trazodone hydrochloride extended-release tablets)

8,133,893

ViiV Healthcare Co. v. Mylan Inc., 12-1065 (D. Del.)

Aug. 22, 2012

Hon. Richard G. Andrews

Lexiva® (fosamprenavir calcium tablets)

6,436,989

Purdue Pharma. Products L.P. v. Actavis Elizabeth LLC, 12-5311 (D.N.J.)

Aug. 23, 2012

Hon. Jose L. Linares

Intermezzo® (zolpidem tartrate tablets)

7,682,628

Janssen Products, L.P. v. Lupin Ltd., 12-5358 (D.N.J.)

Aug. 24, 2012

Hon. William H. Walls

Prezista® (darunavir tablets)

RE43,596

Purdue Pharma. Products L.P. v. Watson Pharma., Inc., 12-5390 (D.N.J.)

Aug. 27, 2012

Hon. Jose L. Linares

Intermezzo® (zolpidem tartrate tablets)

7,682,628

Merck & Co., Inc. v. Sun Pharma. Indus., Ltd., 12-5374 (D.N.J.)

Aug. 27, 2012

Hon. Freda L. Wolfson

Ganirelix Acetate Injection

5,757,082

6,653,286

Mallinckrodt, LLC v. Apotex Inc., 12-1087

Aug. 30, 2012

Hon. Mary Pat Thynge

Pennsaid® (diclofenac sodium topical solution)

8,217,078

AbbVie, Inc. v. Amneal Pharma., LLC, 12-1088 (D. Del.)

Aug. 30, 2012

Hon. Sue L. Robinson

Niaspan® (niacin extended-release tablets)

6,080,428

GlaxoSmithKline LLC v. Apotex Inc., 12-1090 (D. Del.)

Aug. 31, 2012

Hon. Richard G. Andrews

Avodart® (dutasteride capsules)

5,565,467

Medicis Pharma. Corp. v. Actavis Mid Atlantic LLC, 12-1091 (D. Del.)

Aug. 31, 2012

Hon. Leonard P. Stark

Zyclara® (imiquimod) Cream (3.75%)

8,236,816

Teva Branded Pharma. Products R&D, Inc. v. Perrigo Pharma. Co., 12-1101 (D. Del.)

Sept. 5, 2012

Hon. Gregory M. Sleet

ProAir® HFA (albuterol sulfate) Inhalation Aerosol

7,105,152

7,566,445

Novartis Pharma. Corp. v. Apotex Inc., 12-5574 (D.N.J.)

Sept. 6, 2012

Hon. Jose L. Linares

Lotrel® (amlodipine / benazepril hydrochloride capsules)

6,162,802

Salix Pharma., Inc. v. Lupin Ltd., 12-1104 (D. Del.)

Sept. 7, 2012

Hon. Gregory M. Sleet

Apriso® (mesalamine extended-release capsules)

6,551,620

Salix Pharma., Inc. v. Lupin Ltd., 12-2708 (D. Md.)

Sept. 10, 2012

Hon. William D. Quarles, Jr.

Apriso® (mesalamine extended-release capsules)

6,551,620

Otsuka Pharma. Co., Ltd. v. Apotex Corp., 12-5645 (D.N.J.)

Sept. 10, 2012

Hon. Mary L. Cooper

Abilify® (aripiprazole oral solution)

6,977,257

5,006,528

Upsher-Smith Labs., Inc. v. Auxilium Pharma., Inc., 12-5648 (D.N.J.)

Sept. 10, 2012

Hon. Jose L. Linares

Testim® 1% (testosterone gel)

7,608,605

7,608,606

7,608,607

7,608,608

7,608,609

7,608,610

7,935,690

8,063,029

Purdue Pharma. Products L.P. v. Novel Labs., Inc., 12-5650 (D.N.J.)

Sept. 10, 2012

Hon. Jose L. Linares

Intermezzo® (zolpidem tartrate tablets)

7,682,628

Braintree Labs., Inc. v. Cypress Pharma., Inc., 12-6851 (S.D.N.Y.)

Sept. 11, 2012

Hon. Alison J. Nathan

Suprep® (sodium sulfate / potassium sulfate / magnesium sulfate oral solution)

6,946,149

Avanir Pharma., Inc. v. Actavis South Atlantic, LLC, 12-1122 (D. Del.)

Sept. 12, 2012

Hon. Leonard P. Stark

Nuedexta® (dextromethorphan hydrobromide / quinidine sulfate capsules)

8,227,484

Avanir Pharma., Inc. v. Par Pharma., Inc., 12-1123 (D. Del.)

Sept. 12, 2012

Hon. Leonard P. Stark

Nuedexta® (dextromethorphan hydrobromide / quinidine sulfate capsules)

8,227,484

Avanir Pharma., Inc. v. Watson Pharma., Inc., 12-1124 (D. Del.)

Sept. 12, 2012

Hon. Leonard P. Stark

Nuedexta® (dextromethorphan hydrobromide / quinidine sulfate capsules)

8,227,484

Avanir Pharma., Inc. v. Wockhardt Ltd., 12-1125 (D. Del.)

Sept. 12, 2012

Hon. Leonard P. Stark

Nuedexta® (dextromethorphan hydrobromide / quinidine sulfate capsules)

8,227,484

Actelion Pharma. Ltd. v. Apotex Inc., 12-5743 (D.N.J.)

Sept. 14, 2012

Hon. Noel L. Hillman

Tracleer® (bosentan tablets)

5,292,740

Otsuka Pharma. Co., Ltd. v. Silarx Pharma., Inc., 12-5809 (D.N.J.)

Sept. 14, 2012

Hon. Mary L. Cooper

Abilify® (aripiprazole oral solution)

6,977,257

Cubist Pharma., Inc. v. Hospira, Inc., 12-1142 (D. Del.)

Sept. 17, 2012

Hon. Gregory M. Sleet

Cubicin® (daptomycin for injection)

6,468,967

6,852,689

RE39,071

8,058,238

8,129,342

Merck Sharp & Dohme Corp. v. Sandoz Inc., 12-6077 (D.N.J.)

Sept. 27, 2012

Hon. Jose L. Linares

Zetia® (ezetimibe tablets)

RE42,461

5,846,966

7,030,106

7,612,058

The articles on our Website include some of the publications and papers authored by our attorneys, both before and after they joined our firm. The content of these articles should not be taken as legal advice.